4.9 (121) · $ 8.00 · In stock
The production of cellular therapies requires the optimization of four steps: first, isolating and culturing cells that can be readily obtained from a patient in a non-invasive fashion. Second, the reprogramming of these cells into a pluripotent state. Third, the directed differentiation of those patient-specific pluripotent cells into the cell type relevant to their disease. And, fourth, techniques for repairing any intrinsic disease-causing genetic defects and transplantation of the repaired, differentiated cells into the patient. Notably, these disease-relevant patient cells can also be used for in vitro disease modeling which may yield new insights into disease mechanisms and drug discovery.
Reprogramming of mouse retinal neurons and standardized
Immunological considerations for cell therapy using human
Commercialization, IPR, and Market of Stem Cell Products
A practical guide to induced pluripotent stem cell research using
Stem cells: past, present, and future
Understanding stem cells and its pivotal role in regenerative
Basic pluripotent stem cell culture protocols - StemBook - NCBI
A roundtable on responsible innovation with autologous stem cells
Lineage analysis of stem cells - StemBook - NCBI Bookshelf
Generation of human induced pluripotent stem cells from peripheral
Molecules, Free Full-Text
Gene-modified, cell-based therapies—an overview - Cytotherapy
Regenerative Medicine Approaches in Bioengineering Female
Age-dependent structural and morphological changes of the stem
Stem cells: past, present, and future